Insider: Girshick Birgit Corporate Executive VP & COO - CHARLES RIVER LABORATORIES INTERNATIONAL INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 55,058 | 0 | 55,058 |
| Value | $8,014,793.06 | $0.00 | $8,014,793.06 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/20/2025 | AAP | 1,514 | Direct | COM | $164.63 | $249,249.82 | 55,058 |
| 11/20/2023 | AAP | 1,322 | Direct | COM | $187.82 | $248,298.04 | 44,449 |
| 02/16/2023 | DDS | 78 | Direct | COM | $250.69 | $19,553.82 | 43,908 |
| 02/16/2023 | DDS | 84 | Direct | COM | $246.13 | $20,674.86 | 44,159 |
| 02/16/2023 | DDS | 183 | Direct | COM | $251.56 | $46,035.35 | 43,725 |
| 02/16/2023 | DDS | 100 | Direct | COM | $248.07 | $24,806.50 | 44,059 |
| 02/16/2023 | DDS | 73 | Direct | COM | $249.22 | $18,193.06 | 43,986 |
| 02/16/2023 | DDS | 157 | Direct | COM | $252.87 | $39,700.26 | 43,568 |
| 02/16/2023 | DDS | 502 | Direct | COM | $256.48 | $128,750.85 | 41,038 |
| 02/16/2023 | DDS | 1,392 | Direct | COM | $255.65 | $355,870.09 | 41,540 |
| 02/16/2023 | DDS | 219 | Direct | COM | $253.78 | $55,577.69 | 43,349 |
| 02/16/2023 | DDS | 417 | Direct | COM | $254.55 | $106,147.14 | 42,932 |
| 09/14/2021 | DDS | 2,344 | Direct | COM | $439.90 | $1,031,125.60 | 27,602 |
| 09/13/2021 | DDS | 2 | Direct | COM | $441.66 | $883.31 | 30,025 |
| 09/13/2021 | DDS | 7 | Direct | COM | $442.73 | $3,099.11 | 29,946 |
| 09/13/2021 | DDS | 72 | Direct | COM | $442.15 | $31,834.80 | 29,953 |
| 04/06/2021 | DDS | 5,986 | Direct | COM | $298.00 | $1,783,828.00 | 29,060 |
| 04/06/2021 | DDS | 6,409 | Direct | COM | $304.85 | $1,953,783.65 | 29,060 |
| 04/06/2021 | DDS | 5,916 | Direct | COM | $304.85 | $1,803,492.60 | 29,060 |
| 04/05/2021 | DDS | 999 | Direct | COM | $298.00 | $297,702.00 | 29,060 |
| 02/19/2021 | DDS | 1,675 | Direct | COM | $293.92 | $492,310.64 | 30,005 |
| 08/20/2020 | DDS | 933 | Direct | COM | $213.51 | $199,204.83 | 22,852 |
| 05/12/2020 | DDS | 780 | Direct | COM | $165.74 | $129,277.20 | 21,837 |
| 02/13/2020 | DDS | 900 | Direct | COM | $172.05 | $154,845.00 | 23,714 |
| 12/09/2019 | DDS | 89 | Direct | COM | $144.83 | $12,889.87 | 20,560 |
| 1 2 3 4 5 6 7 Next Last You are at page 1 of 7 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research